XRE Luciferase Reporter Lentivirus (AhR Signaling)
BPS-78672 500 µl x 2
Data Sheet: 
Applications
Screen for activators or inhibitors of the AhR signaling pathway.
Generate a XRE luciferase reporter stable cell line (puromycin resistant) following puromycin selection and limiting dilution
Shipment
-80°C (dry ice)
Description
The Xenobiotic response element (XRE) Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce most types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by three copies of an XRE located upstream of the minimal TATA promoter (Figure 1), and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, the activation of aryl hydrocarbon receptor (AhR) in the target cells can be monitored by measuring the luciferase activity. - Screen for activators or inhibitors of the AhR signaling pathway.
Generate a XRE luciferase reporter stable cell line (puromycin resistant) following puromycin selection and limiting dilution
- Avoid freeze/thaw cycles.
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
